China Pharma Holdings (CPHI) Receivables - Other (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Receivables - Other came in at $61657.0 in Q1 2026, up 57.91% YoY from $39046.0 in Q1 2025, and up 25.16% on a QoQ basis from $49261.0 in Q4 2025.
China Pharma Holdings (CPHI) Receivables - Other (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 16 years of Receivables - Other data on file, last reported at $61657.0 in Q1 2026.
- Quarterly Receivables - Other rose 57.91% year-over-year to $61657.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $61657.0 (up 57.91% YoY) and the FY2025 annual result came in at $49261.0, up 62.65% from the prior year.
- Receivables - Other climbed to $61657.0 in Q1 2026, from $49261.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $1.2 million in Q1 2022 to a low of $28660.0 in Q2 2024.
- A 5-year average of $270495.4 and a median of $48361.0 in 2025 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2022 — Receivables - Other slumped 97.96% — and 2023, when it soared 442.04%.
- Tracing CPHI's Receivables - Other over 5 years: stood at $29139.0 in 2022, then soared by 442.04% to $157944.0 in 2023, then tumbled by 80.82% to $30286.0 in 2024, then surged by 62.65% to $49261.0 in 2025, then advanced by 25.16% to $61657.0 in 2026.
- The last three Receivables - Other figures came in at $61657.0 (Q1 2026), $49261.0 (Q4 2025), and $61275.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | China Pharma Holdings | 42.55 Mn | 42.24 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61,657.00 |
| Mar 31, 2026 | 61,657.00 |
| Dec 31, 2025 | 49,261.00 |
| Dec 31, 2025 | 49,261.00 |
| Sep 30, 2025 | 61,275.00 |
| Sep 30, 2025 | 61,275.00 |
| Jun 30, 2025 | 48,361.00 |
| Jun 30, 2025 | 48,361.00 |
| Mar 31, 2025 | 39,046.00 |
| Mar 31, 2025 | 39,046.00 |
| Dec 31, 2024 | 30,286.00 |
| Dec 31, 2024 | 30,286.00 |
| Sep 30, 2024 | 46,553.00 |
| Sep 30, 2024 | 46,553.00 |
| Jun 30, 2024 | 28,660.00 |
| Jun 30, 2024 | 28,660.00 |
| Mar 31, 2024 | 32,220.00 |
| Mar 31, 2024 | 32,220.00 |
| Dec 31, 2023 | 157,944.00 |
| Dec 31, 2023 | 157,944.00 |